Wellington Management Group
TLSI icon

Wellington Management Group’s TriSalus Life Sciences TLSI Stock Holding History

Wellington Management Group’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-215,024
Closed -$2.13M – 2294
2021
Q3 		$2.13M Hold
215,024
– – ﹤0.01% 1671
2021
Q2 		$2.1M Sell
215,024
-139,305
-39% -$1.37M ﹤0.01% 1667
2021
Q1 		$3.42M Buy
+354,329
New +$3.59M ﹤0.01% 1512

Other funds holding TLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Wellington Management Group's TLSI Position: Q4 2021 in Review

Wellington Management Group sold out of TriSalus Life Sciences (TLSI) in Q4 2021, closing a stake of 215,024 shares — an estimated $2.13M sold.

Wellington Management Group first reported a position in TLSI in Q1 2021 and held it in 3 quarters. The position peaked at $3.42M in Q1 2021. 68 funds tracked by Wall St. Rank hold TLSI as of Q4 2021.

  • Wellington Management Group reported no remaining TriSalus Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Wellington Management Group sold 215,024 TriSalus Life Sciences shares in Q4 2021, an estimated $2.13M.
  • Wellington Management Group first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 3 quarters.
  • Wellington Management Group's TriSalus Life Sciences position peaked at $3.42M in Q1 2021.
  • 68 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2021.

Based on Wellington Management Group's 13F filing for Q4 2021, filed 11 Feb 2022.